Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931831 | 1.00 | AKR1C4 (0.45) | AKR1C4AKR1C3AKR1C2PTGS1 | |
| SCHEMBL2477637 | 0.84 | AKR1C4 (0.33) | AKR1C4AKR1C3AKR1C2PTGS1 | |
| SCHEMBL2478484 | 0.84 | AKR1C4 (0.33) | AKR1C4AKR1C3AKR1C2PTGS1 | |
| SCHEMBL10385820 | 0.77 | AKR1C4 (0.40) | AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL28625241 | 0.77 | TLR4 (0.33) | — | |
| SCHEMBL234408 | 0.75 | PRKCA (0.37) | — | |
| SCHEMBL2240463 | 0.75 | PRKCA (0.37) | — | |
| SCHEMBL28619636 | 0.74 | PRKCA (0.39) | — | |
| SCHEMBL11804557 | 0.73 | AKR1C4 (0.38) | AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL57727 | 0.73 | AKR1C4 (0.38) | AKR1C4AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50250-E1 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | FIRMENICH SA (CH) | 2024-12-31 | — | — | US | claimed |
| US-11339113-B2 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | FIRMENICH SA (CH) | 2022-05-24 | — | — | US | claimed |
| US-20210323904-A1 | PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES | FIRMENICH SA (CH) | 2021-10-21 | — | — | US | claimed |
| EP-3823954-A1 | PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES | Firmenich SA (CH) | 2021-05-26 | — | — | EP | claimed |
| CN-112638861-A | Process for preparing cis-alpha, beta-substituted cyclopentanones | 弗门尼舍有限公司 | 2021-04-09 | — | — | CN | claimed |
| WO-2020127094-A1 | PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES | FIRMENICH SA (CH) | 2020-06-25 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-8586621-B2 | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles | BIORESPONSE, L.L.C. | 2013-11-19 | — | — | US | claimed |
| WO-2008057253-A2 | ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES | BIORESPONSE, L.L.C. (US) | 2008-05-15 | — | — | WO | claimed |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | L'OREAL S.A. (FR) | 2003-12-04 | — | — | US | claimed |
| US-20250312349-A1 | COMPOSITION AND METHODS OF TREATING INTRACELLULAR PATHOGEN INFECTION | UNIV HOSPITALS CLEVELAND MEDICAL CENTER (US) | 2025-10-09 | — | — | US | disclosed |
| US-RE50250-E1 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | FIRMENICH SA (CH) | 2024-12-31 | — | — | US | disclosed |
| US-11339113-B2 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | FIRMENICH SA (CH) | 2022-05-24 | — | — | US | disclosed |
| CN-113575344-A | Anti-season seedling transplanting method by using growth regulator to pick leaves | 北京市园林绿化集团有限公司 | 2021-11-02 | — | — | CN | disclosed |
| US-20210323904-A1 | PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES | FIRMENICH SA (CH) | 2021-10-21 | — | — | US | disclosed |
| US-20050187299-A1 | Process for the preparation of alkylidenecyclopentanone derivatives | FIRMENICH S.A. (CH) | 2005-08-25 | — | — | US | disclosed |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | L'OREAL S.A. (FR) | 2003-12-04 | — | — | US | disclosed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | disclosed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | DHPS, DOHH, PORCN | AKR1C4 763/4885AKR1C3 1710/4885AKR1C2 1246/4885 |
| US-11339113-B2 | Process for the preparation of cis-alpha,beta substituted cyclopentanones | CYP4A11, CYP11B1, CYP51A1 | AKR1C4 19/4885AKR1C3 16/4885AKR1C2 29/4885 |
| US-20210323904-A1 | PROCESS FOR THE PREPARATION OF CIS-ALPHA,BETA SUBSTITUTED CYCLOPENTANONES | CYP4A11, CYP11B1, CYP51A1 | AKR1C4 19/4885AKR1C3 16/4885AKR1C2 29/4885 |
| US-20030224024-A1 | Compositions comprising cyclopentane derivatives and their use | CBR1, CBR3, DECR1 | AKR1C4 34/4885AKR1C3 23/4885AKR1C2 71/4885 |
| US-20050187299-A1 | Process for the preparation of alkylidenecyclopentanone derivatives | CYP1B1, AKR1C3, CYP1A1 | AKR1C4 7/4885AKR1C3 2/4885AKR1C2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.